Biological Sciences Division
Published February 8, 2018 | Version v1
Patent Open

METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISM AND PROSTATE CANCER

Creators

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Methods are directed to the treatment of subjects with prostate cancer, in particular those with castration resistant prostate cancer, with glucocorticoid receptor antagonists. The prostate cancer may be one that has become resistant to androgen deprivation therapy, for example, by increase in glucocorticoid receptor expression and/or activity.

Files

US20180036318.pdf

Files (1.4 MB)

Name Size Download all
md5:57a03707db607070414d661c2bd374e7
1.4 MB Preview Download

Additional details

Identifiers

Patent number
US 2018/0036318 A1
Patent application number
US 201715704726 A
Other
oai:uchicago.tind.io:6723

Dates

Patent filed
2017-09-14

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine